Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunohistochemical staining in malignant mesotheliomas.

J G Strickler1, B G Herndier, R V Rouse

  • 1Department of Pathology, Stanford University Medical Center, California 94305.

American Journal of Clinical Pathology
|November 1, 1987
PubMed
Summary

Evaluating five antibodies for distinguishing mesothelioma from adenocarcinoma, this study found none were fully effective alone. Combined use of carcinoembryonic antigen (CEA) and Leu-M1 antibodies may aid diagnosis with other methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Education and imaging. Gastrointestinal: Gastric involvement in disseminated lymphadenopathic Kaposi sarcoma.

Journal of gastroenterology and hepatology·2015
Same author

Care within a veterans hospital: earlier detection of colon cancer.

Surgical endoscopy·2007
Same author

Tetracycline induced green conjunctival pigment deposits.

The British journal of ophthalmology·2005
Same author

Sequence analysis of HIV-1 insertion sites in peripheral blood lymphocytes.

Cellular and molecular biology (Noisy-le-Grand, France)·2002
Same author

Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development.

Immunological reviews·2002
Same author

Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type.

The American journal of surgical pathology·2001

Area of Science:

  • Immunohistochemistry
  • Surgical Pathology
  • Oncology Diagnostics

Background:

  • Distinguishing malignant mesothelioma from metastatic adenocarcinoma is crucial for patient treatment and prognosis.
  • Traditional diagnostic methods include histochemistry and electron microscopy, but immunohistochemistry offers potential for improved accuracy.
  • Several antibodies are used in diagnosing carcinomas, but their efficacy in differentiating mesothelioma requires further investigation.

Purpose of the Study:

  • To evaluate the diagnostic utility of five antibodies in distinguishing between mesothelioma and metastatic adenocarcinoma.
  • To assess the sensitivity and specificity of individual antibodies on routinely processed tissue samples.
  • To determine if any antibody, alone or in combination, can reliably differentiate these two malignancies.

Related Experiment Videos

Main Methods:

  • Six cases of mesothelioma were analyzed using five antibodies: AE1 (anti-keratin), HMFG-2, anti-epithelial membrane antigen, anti-carcinoembryonic antigen (CEA), and anti-Leu-M1.
  • All diagnoses were confirmed using electron microscopy and histochemical stains (PAS-diastase for neutral mucin, alcian blue for acid mucin).
  • Immunoreactivity of each antibody was assessed on routinely processed, paraffin-embedded tissue sections.

Main Results:

  • AE1, HMFG-2, and anti-epithelial membrane antigen showed reactivity in all six mesothelioma cases, indicating lack of specificity.
  • Anti-CEA and anti-Leu-M1 did not react with any of the mesothelioma samples, suggesting potential specificity but limited sensitivity.
  • No single antibody demonstrated both high sensitivity and specificity for distinguishing mesothelioma from adenocarcinoma.

Conclusions:

  • None of the evaluated antibodies, when used independently on routine samples, are sufficient for definitive differentiation.
  • Anti-CEA and anti-Leu-M1 may be valuable adjuncts when used with other diagnostic modalities like histochemistry and electron microscopy.
  • Further research into combined antibody panels and advanced techniques is warranted for improved diagnostic accuracy.